Human Immunodeficiency Virus Rapid Test Kits Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, China - Size and Forecast 2024-2028

Published: Oct 2023 Pages: 164 SKU: IRTNTR45322

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2024-2028

The global human immunodeficiency virus (HIV) rapid test kits market size is estimated to grow by USD 294.96 million at a CAGR of 6.52% between 2023 and 2028.  

Key Findings:

  • The human immunodeficiency virus (HIV) rapid test kits market remained historically at high levels from 2018 to 2023.
  • The market is segmented into End-user, Type, and Geography.
  • The diagnostic centers category under the End-user segment generated the largest revenue in 2018.
  • Key regions boosting the market growth include North America, Europe, Asia, and Rest of World (ROW).

Human immunodeficiency virus (HIV) rapid test kits market Share

For More Highlights About this Report, Download Free Sample in a Minute 

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market: Key Drivers, Trends and Challenges

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Driver

The high prevalence of HIV is the key factor driving market growth. AIDS, driven by HIV infection, has become a global health hazard, leading to millions of individuals being diagnosed with the disease. The vast majority of people living with HIV infection are from low- and middle-income countries. The Sub-Saharan African region and Asia-Pacific regions are greatly impacted by the disease. In this regard, many market players are offering innovative and efficient products for HIV diagnosis.

For example, QIAGEN offers Artus HI Virus-1 RT-PCR Kits CE, which provides reliable HIV-1 RNA detection and quantitation for in-vitro diagnostic use. The kit uses manual sample preparation and assay setup techniques. The kit offers a Complete Conformite Europeene - in-vitro Diagnostic device (CE-IVD) compliant workflow from sample collection to detection. Hence, such factors are expected to drive the growth of the market during the forecast period.

Key Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Trends

Efforts to increase pre-marital screenings for HIV is the primary trend shaping market growth. Despite the implementation of various prevention measures to mitigate HIV, every year, millions of individuals become infected by it. Thus, to control and prevent this global health threat, many policies and initiatives have been examined and enforced by different governments across the globe. One such initiative includes pre-marital screening.

Moreover, pre-marital screening test includes a health assessment of soon-to-be-married couples to identify the presence of infectious, genetic diseases and STDs to prevent further risk of transmitting any disease between couples and their children. With growing awareness about the benefits of pre-marital screening, there has been a rise in such testing programs. Hence, the rising focus on pre-marital screening for HIV will drive the growth of the market during the forecast period.

Major Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Challenge

Limited healthcare services in developing regions is a challenge that affects market growth. A considerable population in developing regions such as Asia-Pacific, the Middle East, and Africa neither have good knowledge about health problems nor admission to healthcare facilities. This movement is prevalent due to a lack of financial and human resources, which is a major obstacle to the promotion of public health and thus increases the HIV-infected population. 

Furthermore, developing countries such as Kenya, Algeria, Afghanistan, and Bangladesh lack technology, infrastructure, and adequate policies to ensure efficient healthcare service delivery. The prevalence of HIV causes high rates of mortality and morbidity, and a lack of financial resources for infrastructure and health systems may impede human immunodeficiency virus rapid test kits market growth. Hence, such factors will adversely affect the growth of the market during the forecast period.

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Segmentations

The end-user segment includes diagnostic centers, hospitals, and clinics. The type segment includes HIV rapid immunoassay test and HIV rapid molecular diagnostic test. The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW).

End-User Segment

The market share growth by the diagnostic centers segment will be significant during the forecast period. The raised awareness among the population pertaining to the benefits of early detection of HIV, the availability of a broad range of HIV rapid tests, and the rising number of healthcare settings offering HIV rapid tests are some of the main attributes that are contributing to the demand for HIV diagnostic services involving HIV rapid test kits. These test kits are used widely to conduct HIV detection tests in diagnostic centers, which is propelling the growth of the HIV rapid test kits market.

Get a glance at the market contribution of various segments Download the PDF Sample

The diagnostic centers segment was valued at USD 369.385 million in 2018. One of the important aspects to be followed at diagnostic centers performing HIV rapid tests is quality assurance testing. A quality assurance program must be performed in every diagnostic center to continuously assess and enhance the processes that are essential in the production of laboratory results. Therefore, the diagnostic centers segment will grow significantly in the global human immunodeficiency virus (HIV) rapid test kits market during the forecast period.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The rising incidence of HIV in North America has spurred demand for rapid HIV test kits, ensuring prompt medical intervention. In the US, CDC data from June 2020 revealed 1.1 million diagnosed HIV cases by the end of 2020, escalating the need for immediate diagnosis. The proliferation of healthcare providers offering STD testing services aligns with CDC recommendations for routine HIV testing, contributing to increased HIV testing demand. Various government and non-government organizations, like the Minority HIV/AIDS Fund and the International Antiviral Society-USA, are actively involved in HIV prevention efforts. In Canada, the Federal Initiative to Address HIV/AIDS aims to mitigate the disease's impact through funding and awareness programs. Mexico's AIDS Healthcare Foundation and the International AIDS Society further contribute to heightened HIV awareness, treatment, and prevention, fostering market growth.

Key Companies in Human Immunodeficiency Virus (HIV) Rapid Test Kits Market

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

AccuQuik Test Kits: The company offers human immunodeficiency virus (HIV) rapid test kits, namely AccuQuik, which is a chromatographic immunoassay for the qualitative detection of antibodies raised against human immunodeficiency virus in human serum, plasma or blood.

The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

  • Abbott Laboratories
  • Amkay Products Pvt. Ltd.
  • Becton Dickinson and Co.
  • Bhat Bio Tech India Pvt Ltd.
  • bioLytical Laboratories Inc.
  • bioMerieux SA
  • Chembio Diagnostics Inc.
  • Danaher Corp.
  • DrSafeHands
  • F. Hoffmann La Roche Ltd.
  • Fujirebio Holdings Inc.
  • Healgen Scientific, LLC
  • Hologic Inc.
  • J. Mitra and Co. Pvt. Ltd.
  • MP Biomedicals Inc.
  • Oragenics Inc.
  • OraSure Technologies Inc.
  • Pathkits Heathcare Pvt. Ltd.
  • SHINE SA

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Scope

Report Coverage

Details

Page number

164

Base year

2023

Historic period

 2018 - 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.52%

Market growth 2024-2028

USD 294.96 million

Market structure

Fragmented

YoY growth 2023-2024(%)

5.45

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 40%

Key countries

US, Canada, UK, Germany, and China

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, AccuQuik Test Kits, Amkay Products Pvt. Ltd., Becton Dickinson and Co., Bhat Bio Tech India Pvt Ltd., bioLytical Laboratories Inc., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DrSafeHands, F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Healgen Scientific, LLC, Hologic Inc., J. Mitra and Co. Pvt. Ltd., MP Biomedicals Inc., Oragenics Inc., OraSure Technologies Inc., Pathkits Heathcare Pvt. Ltd., and SHINE SA

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download PDF Sample

What are the Key Data Covered in this Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2024 and 2028
  • Precise estimation of the size of the market  size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behaviour
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global human immunodeficiency virus (HIV) rapid test kits market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global human immunodeficiency virus (hiv) rapid test kits market 2018 - 2022 ($ million)
    • 4.2 End-user Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • 4.3 Type Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Diagnostic centers - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Diagnostic centers - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Diagnostic centers - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Diagnostic centers - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Diagnostic centers - Year-over-year growth 2023-2028 (%)
    • 6.4 Hospitals and clinics - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by End-user
      • Exhibit 42: Market opportunity by End-user ($ million)
      • Exhibit 43: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Exhibit 44: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on Type - Market share 2023-2028 (%)
    • 7.2 Comparison by Type
      • Exhibit 46: Chart on Comparison by Type
      • Exhibit 47: Data Table on Comparison by Type
    • 7.3 HIV rapid immunoassay test - Market size and forecast 2023-2028
      • Exhibit 48: Chart on HIV rapid immunoassay test - Market size and forecast 2023-2028 ($ million)
      • Exhibit 49: Data Table on HIV rapid immunoassay test - Market size and forecast 2023-2028 ($ million)
      • Exhibit 50: Chart on HIV rapid immunoassay test - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on HIV rapid immunoassay test - Year-over-year growth 2023-2028 (%)
    • 7.4 HIV rapid molecular diagnostic test - Market size and forecast 2023-2028
      • Exhibit 52: Chart on HIV rapid molecular diagnostic test - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on HIV rapid molecular diagnostic test - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on HIV rapid molecular diagnostic test - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on HIV rapid molecular diagnostic test - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by Type
      • Exhibit 56: Market opportunity by Type ($ million)
      • Exhibit 57: Data Table on Market opportunity by Type ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 59: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 61: Chart on Geographic comparison
      • Exhibit 62: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 UK - Market size and forecast 2023-2028
      • Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.9 China - Market size and forecast 2023-2028
      • Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.10 Germany - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.11 Canada - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 99: Market opportunity by geography ($ million)
      • Exhibit 100: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 101: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 103: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 104: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 105: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 106: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 107: Abbott Laboratories - Overview
              • Exhibit 108: Abbott Laboratories - Business segments
              • Exhibit 109: Abbott Laboratories - Key news
              • Exhibit 110: Abbott Laboratories - Key offerings
              • Exhibit 111: Abbott Laboratories - Segment focus
            • 12.4 AccuQuik Test Kits
              • Exhibit 112: AccuQuik Test Kits - Overview
              • Exhibit 113: AccuQuik Test Kits - Product / Service
              • Exhibit 114: AccuQuik Test Kits - Key offerings
            • 12.5 Becton Dickinson and Co.
              • Exhibit 115: Becton Dickinson and Co. - Overview
              • Exhibit 116: Becton Dickinson and Co. - Business segments
              • Exhibit 117: Becton Dickinson and Co. - Key news
              • Exhibit 118: Becton Dickinson and Co. - Key offerings
              • Exhibit 119: Becton Dickinson and Co. - Segment focus
            • 12.6 bioLytical Laboratories Inc.
              • Exhibit 120: bioLytical Laboratories Inc. - Overview
              • Exhibit 121: bioLytical Laboratories Inc. - Product / Service
              • Exhibit 122: bioLytical Laboratories Inc. - Key offerings
            • 12.7 bioMerieux SA
              • Exhibit 123: bioMerieux SA - Overview
              • Exhibit 124: bioMerieux SA - Product / Service
              • Exhibit 125: bioMerieux SA - Key news
              • Exhibit 126: bioMerieux SA - Key offerings
            • 12.8 Chembio Diagnostics Inc.
              • Exhibit 127: Chembio Diagnostics Inc. - Overview
              • Exhibit 128: Chembio Diagnostics Inc. - Product / Service
              • Exhibit 129: Chembio Diagnostics Inc. - Key offerings
            • 12.9 Danaher Corp.
              • Exhibit 130: Danaher Corp. - Overview
              • Exhibit 131: Danaher Corp. - Business segments
              • Exhibit 132: Danaher Corp. - Key news
              • Exhibit 133: Danaher Corp. - Key offerings
              • Exhibit 134: Danaher Corp. - Segment focus
            • 12.10 DrSafeHands
              • Exhibit 135: DrSafeHands - Overview
              • Exhibit 136: DrSafeHands - Product / Service
              • Exhibit 137: DrSafeHands - Key offerings
            • 12.11 F. Hoffmann La Roche Ltd.
              • Exhibit 138: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 139: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 140: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 141: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 142: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.12 Fujirebio Holdings Inc.
              • Exhibit 143: Fujirebio Holdings Inc. - Overview
              • Exhibit 144: Fujirebio Holdings Inc. - Product / Service
              • Exhibit 145: Fujirebio Holdings Inc. - Key offerings
            • 12.13 Healgen Scientific, LLC
              • Exhibit 146: Healgen Scientific, LLC - Overview
              • Exhibit 147: Healgen Scientific, LLC - Product / Service
              • Exhibit 148: Healgen Scientific, LLC - Key offerings
            • 12.14 Hologic Inc.
              • Exhibit 149: Hologic Inc. - Overview
              • Exhibit 150: Hologic Inc. - Business segments
              • Exhibit 151: Hologic Inc. - Key news
              • Exhibit 152: Hologic Inc. - Key offerings
              • Exhibit 153: Hologic Inc. - Segment focus
            • 12.15 J. Mitra and Co. Pvt. Ltd.
              • Exhibit 154: J. Mitra and Co. Pvt. Ltd. - Overview
              • Exhibit 155: J. Mitra and Co. Pvt. Ltd. - Product / Service
              • Exhibit 156: J. Mitra and Co. Pvt. Ltd. - Key offerings
            • 12.16 MP Biomedicals Inc.
              • Exhibit 157: MP Biomedicals Inc. - Overview
              • Exhibit 158: MP Biomedicals Inc. - Key offerings
            • 12.17 OraSure Technologies Inc.
              • Exhibit 159: OraSure Technologies Inc. - Overview
              • Exhibit 160: OraSure Technologies Inc. - Business segments
              • Exhibit 161: OraSure Technologies Inc. - Key offerings
              • Exhibit 162: OraSure Technologies Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 163: Inclusions checklist
                • Exhibit 164: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 165: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 166: Research methodology
                • Exhibit 167: Validation techniques employed for market sizing
                • Exhibit 168: Information sources
              • 13.5 List of abbreviations
                • Exhibit 169: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              human immunodeficiency virus (hiv) rapid test kits market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis